Dr. Michael Paul Link, MD is a Pediatrician (Kids / Children Specialist) - Pediatric Hematology-Oncology practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.… Read more ›
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Stanford University School of Medicine- Stanford Ca | Other Degree | 1974 |
| Institution | Focus | Year |
|---|---|---|
| Internship - Children's Hospital Boston, Boston MA | 1975 | |
| Internship - Children's Hospital Boston MA | 1975 | |
| Residency - Children'S Hospital, Hematology-Internal Medicine; Children'S Hospital, Immunology; Children'S Hospital, Pediatrics | Not Specified | |
| Residency - Children's Hospital Boston | 1976 | |
| Fellowship - Children's Hospital Boston, Boston MA | 1979 | |
| Fellowship - Dana-Farber Cancer Institute, Boston MA | 1979 | |
| Fellowship - Dana-Farber Cancer Institute MA | 1979 | |
| Fellowship - Children's Hospital Boston MA | 1979 |
| Certification | Cert. Body | Year |
|---|---|---|
| Pediatrics | Pediatrics | Not Specified |
| Pediatrics | Pediatrics | 1979 |
| Pediatrics Sub-Specialty: Pediatric Hematology-Oncology | Dermatology | Not Specified |
| Pediatrics Sub-Specialty: Pediatric Hematology-Oncology | Dermatology | 1980 |
| Position | Organization | Time |
|---|---|---|
| Member | President-Elect, American Society of Clinical Oncology | 2010 - 2011 |
| Member | Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine | 2000 - 2010 |
| Director | Center for Cancer and Blood Diseases, Lucile Packard | Present |
| Member | Children's Hospital at Stanford | 2002 - 2010 |
| Lydia J. Lee Professor | Pediatric Cancer, Stanford University | 2003 - 2014 |
| Member | President, American Society of Clinical Oncology | 2011 - 2012 |
| Distinction | Institution | Year |
|---|---|---|
| Annual Memorial Lectureship, Pediatric Cancer Research Foundation | 2004 | |
| Washington University School of Medicine | Ben Abelson Memorial Visiting Professor | 2000 |
| Alpha Omega Alpha, Alpha Omega Alpha | 1974 | |
| 21st Annual W.W. Sutow Visiting Lecturer in Pediatric Oncology, MD An | 2013 | |
| Brent Eley Visiting Professor in Pediatric Oncology, | University of Colorado Cancer Center and the Childrens Hospital, Denve | 2009 |
| Phi Beta Kappa | ||
| The Royal Academy of Paediatrics and Child Health (June) | Honorary Fellow | 2013 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Adolescent and Young Adult Oncology, Version 2.2014 | 2014 |
| Other Publication | PEDIATRIC BLOOD & CANCER | Relapse after treatment of pediatric hodgkin lymphoma | 2013 |
| Other Publication | NEW ENGLAND JOURL OF MEDICINE | The Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine | 2012 |
| Other Publication | BLOOD CANCER JOURL | Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia | 2012 |
| Other Publication | Jourl of the tiol Comprehensive Cancer Network | Adolescent and young adult oncology. Clinical practice guidelines in oncology. | 2012 |
| Other Publication | PEDIATRIC BLOOD & CANCER | ALK+ aplastic large cell lymphoma exhibits phosphatidylinositol-3 kise | 2012 |
| Other Publication | JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION | Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy | 2012 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Chemotherapy Drug Shortages in the United States: Genesis and Potential Solutions | 2012 |
| Other Publication | PEDIATRIC NEUROSURGERY | Complete Ocular Paresis in a Child with Posterior Fossa Syndrome | 2012 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Second Malignt Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low | 2010 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | The Impact of the Privacy Rule on Cancer Research | 2009 |
| Other Publication | PEDIATRIC BLOOD & CANCER | Non-aplastic peripheral T-cell lymphoma in childhood and adolescence | 2008 |
| Other Publication | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | Nodular lymphocyte-predomint Hodgkin lymphoma presenting as fulmint hepatic failure in a pediatric | 2008 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival | 2008 |
| Other Publication | PEDIATRIC BLOOD & CANCER | Treatment of metastatuc Ewing Sarcoma | 2007 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Fil results of a prospective clinical trial with VAMP | 2007 |
| Other Publication | BLOOD | Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive | 2007 |
| Other Publication | BIOELECTROMAGNETICS | Magnetic field exposure and prognostic factors in childhood leukemia | 2007 |
| Other Publication | BRITISH JOURL OF CANCER | Magnetic field exposure and long-term survival among children with leukaemia | 2006 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis | 2006 |
| Other Publication | PEDIATRIC AND DEVELOPMENTAL PATHOLOGY | Review of tonsillar lymphoma in pediatric patients from the Pediatric Oncology Group | 2005 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and | 2005 |
| Other Publication | PEDIATRIC BLOOD & CANCER | Epstein-Barr virus-associated peripheral T-cell lymphoma | 2005 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | High-dose therapy and autologous hematopoietic stem | 2004 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Risk-adapted, combined-modality therapy with VAMP | 2004 |
| Other Publication | CLINICAL CANCER RESEARCH | Cyclophosphamide dose intensification during induction therapy for intermediate | 2004 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone | 2004 |
| Other Publication | CANCER | High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma | 2004 |
| Other Publication | Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendric | tiol Institutes of Health State-of-the-Science Conference Statement: Symptom Magement in Cancer | |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy | 2003 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Presurgical chemotherapy compared with immediate surgery | 2003 |
| Other Publication | NEW ENGLAND JOURL OF MEDICINE | Addition of ifosfamide and etoposide to standard chemotherapy | 2003 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Prognostic factors and clinical outcomes | 2003 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Children from ethnic minorities have benefited equally | 2002 |
| Other Publication | CA: a cancer jourl for clinicians | tiol action plan for childhood cancer: report of the tiol summit meetings on childhood cancer. | 2002 |
| Other Publication | PEDIATRIC CLINICS OF NORTH AMERICA | Assessment of lymphadenopathy in children | 2002 |
| Other Publication | STATISTICS IN MEDICINE | Minimax two-stage-designs with applications to tissue banking case-control studies | 2002 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose | 2002 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | VAMP and low-dose, involved-field radiation for children and adolescents with favorable | 2002 |
| Other Publication | LEUKEMIA | Bone marrow stroma-supported culture of T | 2002 |
| Other Publication | CLINICAL CANCER RESEARCH | Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin | 2002 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Phase II/III trial of etoposide and high-dose ifosfamide | 2002 |
| Other Publication | MEDICAL AND PEDIATRIC ONCOLOGY | Efficacy of ifosfamide | 2001 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Which patients with microscopic disease | 2001 |
| Other Publication | Semirs in pediatric surgery | Controversies in the magement of paratesticular rhabdomyosarcoma | 2001 |
| Other Publication | JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGY | Presurgical window of carboplatin and surgery and multidrug chemotherapy | 2001 |
| Other Publication | Arndt, C. A., Doldson, S. S., Anderson, J. R., Andrassy, R. J., Laurie | What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? | 2001 |
| Other Publication | JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGY | Thyroid carcinoma after successful treatment of osteosarcoma: A report of three patients | 2001 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Attitudes and practices among pediatric oncologists regarding end-of-life care | 2001 |
| Other Publication | BLOOD | New recurring cytogenetic abnormalities | 2000 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Benefit of intensified therapy for patients with local or regiol embryol rhabdomyosarcoma | 2000 |
| Other Publication | LEUKEMIA | Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia | 2000 |
| Other Publication | Hutchison, R. E., Finch, C., Kepner, J., Fuller, C., Bowman, P., Link, | Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons | 2000 |
| Other Publication | LEUKEMIA | Significance of commonly used prognostic factors differs | 1999 |
| Other Publication | LEUKEMIA | Intensive high-dose asparagise consolidation improves survival for pediatric patients with T cell | 1999 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Treatment of localized primary non-Hodgkin's lymphoma of bone in children | 1999 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Childhood acute lymphoblastic leukemia with the MLL-ENL fusion | 1999 |
| Other Publication | LEUKEMIA | Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation | 1999 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Treatment of metastatic osteosarcoma at diagnosis: A pediatric oncology group study | 1998 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | A multidiscipliry study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346 | 1998 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Randomized trial of r | 1998 |
| Other Publication | BLOOD | E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome | 1998 |
| Other Publication | MEDICAL AND PEDIATRIC ONCOLOGY | Fractioted cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside | 1997 |
| Other Publication | NEW ENGLAND JOURL OF MEDICINE | Treatment of children and young adults with early-stage non-Hodgkin's lymphoma | 1997 |
| Other Publication | LEUKEMIA | Lack of ETV6 (TEL) gene rearrangements or p16(INK4A) | 1997 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Altered expression of p53 | 1997 |
| Other Publication | JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGY | A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the | 1997 |
| Other Publication | CANCER RESEARCH | Frequent and selective methylation of p15 and deletion of both p15 and p16 in T | 1997 |
| Other Publication | BLOOD | Case-control study suggests a favorable impact of TEL rearrangement in patients with B | 1997 |
| Other Publication | ANLS OF ONCOLOGY | Use of an anti-ALK antibody in the characterization of aplastic large-cell lymphoma of childhood | 1997 |
| Other Publication | Oncology (Williston Park, N.Y.) | NCCN pediatric osteosarcoma practice guidelines. The tiol Comprehensive Cancer Network. | 1996 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Improved survival for children with B-cell acute lymphoblastic leukemia | 1996 |
| Other Publication | BLOOD | High incidence of potential p53 ictivation | 1996 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Uniform approach to risk classification | 1996 |
| Other Publication | EXPERIMENTAL HEMATOLOGY | STAGE-SPECIFIC AND LINEAGE | 1995 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | B-CELL LINEAGE CONFERS A FAVORABLE OUTCOME AMONG CHILDREN AND ADOLESCENTS WITH LARGE | 1995 |
| Other Publication | MEDICAL AND PEDIATRIC ONCOLOGY | SAFETY AND EFFICACY OF L-LEUCOVORIN RESCUE FOLLOWING HIGH-DOSE METHOTREXATE FOR OSTEOSARCOMA | 1995 |
| Other Publication | MEDICAL AND PEDIATRIC ONCOLOGY | TREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE IN PEDIATRIC | 1995 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | ABVD/MOPP AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY | 1994 |
| Other Publication | JOURL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS | HYPNOSIS IN THE PREVENTION OF CHEMOTHERAPY-RELATED USEA AND VOMITING IN CHILDREN | 1994 |
| Other Publication | BLOOD | FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF HRX REARRANGEMENTS IN INFANT ACUTE LYMPHOBLASTIC | 1994 |
| Other Publication | LEUKEMIA | SIMULTANEOUS EXPRESSION OF RBTN-2 AND BCR | 1994 |
| Other Publication | CANCER GENETICS AND CYTOGENETICS | PRESENTING CHARACTERISTICS OF TRISOMY | 1994 |
| Other Publication | HUMAN PATHOLOGY | MIC2 ALYSIS IN PEDIATRIC LYMPHOMAS AND LEUKEMIAS | 1994 |
| Other Publication | HUMAN PATHOLOGY | EWINGS-SARCOMA - ROUTINE DIAGNOSTIC UTILIZATION OF MIC2 ALYSIS - A PEDIATRIC-ONCOLOGY-GROUP | 1994 |
| Other Publication | MEDICAL AND PEDIATRIC ONCOLOGY | SECONDARY BREAST-CANCER IN PATIENTS PRESENTING WITH OSTEOSARCOMA | 1994 |
| Other Publication | Cleary, S. F., Link, M. P., Doldson, S. S. | HODGKINS-DISEASE IN THE VERY YOUNG | 1994 |
| Other Publication | HISTOPATHOLOGY | IMMUNOCYTOCHEMICAL STUDY OF 12E7 IN SMALL ROUND-CELL TUMORS OF CHILDHOOD | 1993 |
| Other Publication | AMERICAN JOURL OF PATHOLOGY | DETECTION OF THE (11 22)(Q24 Q12) TRANSLOCATION OF EWINGS | 1993 |
| Other Publication | BLOOD | HRX INVOLVEMENT IN DENOVO AND SECONDARY LEUKEMIAS WITH DIVERSE CHROMOSOME 11Q23 ABNORMALITIES | 1993 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | ACUTE HYPERSENSITIVITY REACTIONS TO ETOPOSIDE IN A VEPA REGIMEN FOR HODGKINS-DISEASE | 1993 |
| Other Publication | Link, M. P., Stevens, J., Friend, S. H., Israel, M. A., Knudson, A. G. | LABORATORY CLINICAL INTERFACE | 1993 |
| Other Publication | BLOOD | CLINICAL-FEATURES AND OUTCOME OF T | 1993 |
| Other Publication | BLOOD | A SERINE PROLINE-RICH PROTEIN IS FUSED TO HRX IN T(4-11) ACUTE LEUKEMIAS | 1993 |
| Other Publication | Cancer treatment and research | The multi-institutiol osteosarcoma study: an update. | 1993 |
| Other Publication | MEDICAL AND PEDIATRIC ONCOLOGY | LANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VE-CAVA SYNDROME - A CASE-REPORT | 1993 |
| Other Publication | Cancer treatment and research | Osteosarcoma in adolescents and young adults | 1993 |
| Other Publication | INVESTIGATIOL NEW DRUGS | A STUDY OF TOXICITY AND COMPARATIVE THERAPEUTIC EFFICACY OF VINDESINE-PREDNISONE VS VINCRISTINE | 1992 |
| Other Publication | LEUKEMIA | CHILDHOOD MALIGNT NON-HODGKIN LYMPHOMAS OF UNCOMMON HISTOLOGY | 1992 |
| Other Publication | LEUKEMIA | MORPHOLOGICAL, IMMUNOLOGICAL AND CYTOGENETIC STUDIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC |
Dr. Michael Paul Link, MD has not yet indicated the hospitals that he is affiliated with.
Pediatrics
Accepts New Patients: Yes
Dr. Michael Paul Link, MD has not yet listed the medications that he commonly prescribes.
Dr. Michael Paul Link, MD has not yet added any information about his practice's billing policies and payment options.
